Daily Financial Update
DAILY KICK · Fri, Sep 12, 2025
Markets moved, news ripped—and you’re about to know why.
Opening Recap
Market Pulse: Tech names surged after Adobe beat Q3 estimates and raised guidance, while Oracle’s AI-friendly results added fuel to the sector’s momentum.
Key Movers: Adobe’s blowout report, Oracle’s under-the-radar AI numbers, and Amneal’s FDA nod for sodium oxybate had traders refreshing their scanners this morning.
Macro & Politics: India’s Nifty is flirting with a festival-season breakout amid chatter that U.S. political rhetoric from Trump could tip global flows.
What’s Next: Watch Fed minutes for hints of a rate tweak and tomorrow’s packed earnings calendar for true surprise catalysts.
Market Commentary
Everyone’s glossing over the cascading fallout from RSV vaccine shortages. Sure, headlines trumpet “breakthrough” shots, but Naturalnews.com lays bare a disaster of broken promises and angry families. When Big Pharma teams up with Big Government, the first casualty is reliability—watch those biotechs mispricing risk as they scramble to fill gaps.
Meanwhile, Oracle’s quiet AI surge and calls for a Diwali rally aren’t unrelated. If Trump’s next political flex sends global capital on a leash, tech firms that actually deliver numbers—like Oracle or Adobe—will see real inflows. Remember, a festival bump in India could melt away faster than you think if U.S. policy volatility spikes.
Action time: lean into names with proven catalysts—Adobe’s guidance, Amneal’s approval—while sidestepping meme stocks and vaccine drama. Keep your stop orders tight; in this market, anything can set off a retracement.
📈 Breaking Financial News
Adobe up 7% following Q3 earnings beat and guidance raise at $373.90
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors
– Dr. Chang led XOLAIR® from invention through FDA approval and commercialization, exceeding $5 billion in sales so far – Los Angeles, CA, Sept. …
Amneal Pharmaceuticals receives FDA approval of sodium oxybate oral solution
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Casey’s General Stores (NASDAQ:CASY) Hits New 52-Week High After Earnings Beat
Casey’s General Stores, Inc. (NASDAQ:CASY – Get Free Report)’s stock price reached a new 52-week high on Tuesday after the company announced better than expected quarterly earnings. The stock traded as high as $533.05 and last traded at $533.45, with a volume…
ID Cards From 9/11 Victims And Survivors That Reveal The Tragedy Of America’s Worst Terrorist Attack
After New York City's Twin Towers were destroyed on September 11, 2001, rescue, recovery, and cleanup workers began uncovering tragic artifacts at Ground Zero — including some victims' damaged ID cards.
This “awesome resource” could power America for 30,000 years…
We sent one of our smartest researchers…. a consultant who's worked for the likes of J.P. Morgan and Citicorp… into the middle of the Utah desert with a film crew. Why? So he could lead an investigation into a radical new kind of energy that's so abundant, the Dept. of Energy says it could meet America's power needs for the next 2 million years. It's got nothing to do with wind, solar, nuclear, oil or gas. This could be huge for early stakeholders – click here for details.
🔍 Market Analysis & Insights
J.P. Morgan Maintains a Buy on Teva Pharmaceutical (TEVA) With a $23 PT
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best growth stocks under $50 to buy now. On September 5, J.P. Morgan analyst Chris Schott…
US stock market rally to new highs: Dow hits record, S&P 500 and Nasdaq reach all-time highs as Nvidia and Micron jump ahead of bigger-than-expected Fed rate cut after jobless claims rise
U.S. stocks are holding near record highs today as investors weigh rising inflation, AI-driven tech gains, and mixed economic signals. The S&P 500 and Nasdaq are leading the rally, boosted by strong performances from Nvidia, Micron, Apple, and Microsoft, whic…
Jim Cramer Shares Why Vertiv Holdings Co (VRT) Is An Important Data Center Stock
We recently published 13 Stocks Jim Cramer Discussed During His Historic Morning Appearance. Vertiv Holdings Co (NYSE:VRT) is one of the stocks Jim Cramer…
Oracle is giving Wall Street numbers it can bet on as Larry Ellison's tech giant becomes investors' new favorite AI play
Oracle's blowout earnings sent the stock skyrocketing, and made Larry Ellison even richer than he already is.
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
— Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth — — Following the Setup Kit, the Insemination Kit completes the sperm preparation portion …
Oil Jumps 8.5% on Middle East Crisis
Oil surged 8.5% to $74/barrel after Israel's Iran strike – biggest jump since 2022. Experts predict $100+ oil if conflict spreads. Don't chase volatile oil stocks. See Marc's safer alternative here
💰 Investment Opportunities
Crypto Market Today: MNT, HASH Shine as Majors Look to U.S. Inflation Report
Market gains may accelerate if the CPI prints below estimates, strengthening the chance of a Federal Reserve rate cut.
Prescription Drugs Market to Surpass USD 2.17 Trillion by 2032, Fueled by Rising Prevalence of Chronic Diseases and Strong U.S. Market Leadership – SNS Insider
U.S. Market Expected to Maintain Dominance with USD 720.90 Billion by 2032, as Oncology, Immunosuppressants, and Specialty Therapies Drive Innovation. U.S. Market Expected to Maintain Dominance with USD 720.90 Billion by 2032, as Oncology, Immunosuppressants,…
Biocon opens first US manufacturing plant in New Jersey
The facility, operated by Biocon’s wholly-owned subsidiary Biocon Generics Inc., produces oral solid dosage medications with an annual capacity of 2 billion tablets
Blood, grief, and broken promises: How the rush for RSV vaccines left mothers and babies in the crossfire
The room was quiet except for the steady beep of monitors and the muffled sobs of a mother cradling her stillborn child. Outside the hospital walls, public health officials were celebrating a new triumph — another vaccine rolled out, another promise of protec…
Diwali rally watch: Is Trump the last piece of the puzzle for Nifty breakout?
Indian stock markets anticipate a potential breakout as Donald Trump signals a trade deal, potentially ending tariff standoffs. This, combined with expected earnings recovery in 2025, GST rate cuts, and anticipated Fed rate cuts, could trigger a significant D…
Claim Your Starlink Pre-IPO Prospectus
This is a critical and time-sensitive message. It's regarding Starlink, which is expected to be the largest IPO in history – set to take place in as little as a few weeks. And for the first time ever, we've found a way for you to profit BEFORE the IPO happens. One of the world's top venture capitalists and Silicon Valley insiders has just released all of the details… including a prospectus… in this short message. Click here now to discover how to take action BEFORE the IPO.